Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Robak, Tadeusz, Kazmierczak, Maciej, Jarque, Isidro, Musteata, Vasile, Trelinski, Jacek, Cooper, Nichola, Kiessling, Peter, Massow, Ute, Woltering, Franz, Snipes, Rose, Ke, Juan, Langdon, Grant, Bussel, James B. and Jolles, Stephen 2020. Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia. Blood Advances 4 (17) , pp. 4136-4146. 10.1182/bloodadvances.2020002003

[img] PDF - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (0B)
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Additional Information: PDF added in accordance with the publisher's policies at http://v2.sherpa.ac.uk/id/publication/32010 (accesses 7/9/20)//
Publisher: American Society of Hematology: Blood Advances
ISSN: 2473-9529
Funders: N/A
Date of First Compliant Deposit: 7 September 2020
Date of Acceptance: 15 July 2020
Last Modified: 07 Sep 2020 07:45
URI: http://orca.cf.ac.uk/id/eprint/134675

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics